You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

has received neoadjuvant therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Surgical Procedure, Unspecified Trial in Shanghai (ROBOTIC-ASSISTED ESOPHAGECTOMY)

Not yet recruiting
  • Surgical Procedure, Unspecified
  • ROBOTIC-ASSISTED ESOPHAGECTOMY
  • Shanghai, China
    Shanghai Chest Hospital, Shanghai Jiao Tong University
Aug 21, 2023

Rectal Cancer Trial (Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy)

Not yet recruiting
  • Rectal Cancer
  • Neoadjuvant Chemoradiotherapy
  • Total Neoadjuvant Therapy
  • (no location specified)
Oct 24, 2023

Postoperative Radiotherapy for Oral Squamous Cell Carcinoma

Recruiting
  • Radiotherapy
  • +3 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Jul 12, 2022

    Breast Cancer Female Trial (Pyrotinib and Trastuzumab)

    Not yet recruiting
    • Breast Cancer Female
    • Pyrotinib and Trastuzumab
    • (no location specified)
    Sep 11, 2023

    Stage II-III Breast Cancer Trial in Shenyang (cytotoxic chemo (docetaxel or epirubicin or cyclophosphamide or carboplatin),

    Recruiting
    • Stage II-III Breast Cancer
    • cytotoxic chemotherapy (docetaxel or epirubicin or cyclophosphamide or carboplatin)
    • +2 more
    • Shenyang, Liaoning, China
    • +1 more
    Aug 3, 2022

    t Pathologic Complete Response Observed in HER2 Positive Breast

    Completed
    • HER2+ Breast Cancer
    • Rawalpindi, Punjab, Pakistan
      Rawalpindi Medical University
    Jun 26, 2023

    NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
    • (no location specified)
    Aug 27, 2023

    Colon Cancer, Neoadjuvant Therapy Trial in Hangzhou (Camrelizumab , apatinib and chemo)

    Recruiting
    • Colon Cancer
    • Neoadjuvant Therapy
    • Camrelizumab , apatinib and chemotherapy
    • Hangzhou, Zhejiang, China
      First affiliated hospital, Zhejiang University
    Jan 27, 2023

    Resectable Hepatocellular Carcinoma Trial (Tislelizumab, Tislelizumab, Lenvatinib)

    Not yet recruiting
    • Resectable Hepatocellular Carcinoma
    • (no location specified)
    Mar 29, 2023

    Gastric Cancer, Peritoneal Metastases Trial (HIPEC)

    Not yet recruiting
    • Gastric Cancer
    • Peritoneal Metastases
    • HIPEC
    • (no location specified)
    Mar 20, 2022

    Bevacizumab Combined With PD-1 Monoclonal Antibody in

    Not yet recruiting
    • Colorectal Cancer
    • Bevacizumab Combined With PD-1 Monoclonal Antibody
    • (no location specified)
    Nov 8, 2023

    Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

    Not yet recruiting
    • Hepatocellular Carcinoma Resectable
    • neoadjuvant therapy
    • Fuzhou, Fujian, China
      The First Affiliated Hospital of Fujian Medical University
    Aug 19, 2023

    Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for

    Recruiting
    • Breast Cancer
    • Tianjin, Tianjin, China
      Jie Ge
    Aug 20, 2023

    Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

    Recruiting
    • Oral Squamous Cell Carcinoma
    • +3 more
    • Camrelizumab (anti-PD-1 inhibitor)
    • Apatinib (anti-VEGFR inhibitor)
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Oct 8, 2022

    Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

    Recruiting
    • Colonic Neoplasms
    • +2 more
    • Nanning, Guangxi, China
      The First Affiliated Hospital of Guangxi Medical University
    Nov 9, 2023

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

    Recruiting
    • Esophageal Carcinoma
    • Neoadjuvant Immunotherapy
    • PD-1 blockade
    • +2 more
    • Beijing, Beijing, China
      Qin li
    Mar 8, 2023

    Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

    Recruiting
    • Non Small Cell Lung Cancer
    • anti-PD-1 or anti-PD-L1
    • +2 more
    • Shanghai, China
      Oncology Department, Shanghai Chest Hospital
    Jul 26, 2022

    Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)

    Recruiting
    • Breast Cancer
    • axillary surgery de-escalation after NAT
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center Shanghai, China, 200032
    Jun 13, 2023

    Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

    Recruiting
    • Gastric Cancer
    • +3 more
    • Fruquintinib + SOX
    • Nanning, China
      Guangxi Medical University Cancer Hospital
    Dec 2, 2022

    SURPASS Retrospective Study

    Completed
    • Breast Cancer
    • +3 more
    • Sentinel lymph node biopsy followed by axillary lymph node dissection
    • (no location specified)
    Mar 20, 2023

    Rectal Cancer Trial in Osaka (radiation, drug, procedure)

    Recruiting
    • Rectal Cancer
    • Radiation
    • +2 more
    • Osaka, Japan
    • +1 more
    Jul 1, 2023

    Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

    Recruiting
    • Oral Squamous Cell Carcinoma
    • +3 more
    • Toripalimab (anti-programmed death-1 inhibitor)
    • +4 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Oct 8, 2022

    Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)

    Recruiting
    • Colon Cancer
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Aug 26, 2023

    Head and Neck Squamous-cell Carcinoma

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
      • (no location specified)
      Nov 5, 2023